Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis

16 Oct 2019

Abstract excerpt

BACKGROUND: Muscle-invasive bladder cancer (MIBC) is a heterogeneous disease, and gene expression profiling has identified several molecular subtypes with distinct biological and clinicopathological characteristics. While MIBC subtyping has primarily been based on messenger RNA (mRNA), long non-coding RNAs (lncRNAs) may provide additional resolution. METHODS: LncRNA expression was quantified from microarray data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31619281
DOI: 10.1186/s13073-019-0669-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosisPMID 31619281Read ↗

The consensus molecular classification of muscle-invasive bladder cancerSemantic proximity Read ↗

Multi-omics consensus ensemble refines the classification of muscle-invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapiesSemantic proximity Read ↗

An integrated molecular classification system identifies distinct prognostic clusters of non-muscle-invasive bladder cancer.Semantic proximity Read ↗

Long non-coding RNAs to predict postoperative recurrence in muscle-invasive bladder cancer and to develop a new molecular classification systemSemantic proximity Read ↗

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.Semantic proximity Read ↗

Integrating transcriptomics, single-cell omics, and deep learning-based histopathological features to identify OLFML3 as in bladder cancerSemantic proximity Read ↗

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.Semantic proximity Read ↗

Deep Learning Bridges Histology and Transcriptomics to Predict Molecular Subtypes and Outcomes in Muscle-Invasive Bladder CancerSemantic proximity Read ↗

An integrated multi-omics analysis identifies clinically relevant molecular subtypes of non-muscle-invasive bladder cancerSemantic proximity Read ↗

Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.Semantic proximity Read ↗

Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancerSemantic proximity Read ↗

Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.